Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
The antidiabetic drug metformin exerts chemopreventive and antineoplastic effects in many types of malignancies. However, the mechanisms responsible for metformin actions appear diverse and may differ in different types of cancer. Understanding the molecular and cellular mechanisms specific for diff...
Main Authors: | Feng, Y, Ke, C, Tang, Q, Dong, H, Zheng, X, Lin, W, Ke, J, Huang, J, Yeung, S-CJ, Zhang, H |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944271/ |
Similar Items
-
RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma
by: Zhang, Lan, et al.
Published: (2015) -
Activation of autophagy flux by metformin downregulates cellular FLICE–like inhibitory protein and enhances TRAIL- induced apoptosis
by: Nazim, Uddin MD, et al.
Published: (2016) -
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
by: Tomic, T, et al.
Published: (2011) -
Correlation of STAT1 with Apoptosis and Cell-Cycle Markers in Esophageal Squamous Cell Carcinoma
by: Zhang, Ying, et al.
Published: (2014) -
The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma
by: Zhang, Ying, et al.
Published: (2014)